| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 10/05/2011 | EP1355676B1 Method of protecting therapeutic compositions from host-mediated inactivation |
| 10/05/2011 | CN102209559A Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof |
| 10/05/2011 | CN102206276A Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| 10/05/2011 | CN102205125A Method for making human pelvic inflammation simulating animal model |
| 10/05/2011 | CN101574350B Application of imatinib mesylate in preparing drugs used for building congenital cataract animal model |
| 10/04/2011 | US8030459 Oxime conjugates and methods for their formation and use |
| 10/04/2011 | US8029787 Method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 10/04/2011 | US8029767 Fluorescent membrane intercalating probes and methods for their use |
| 10/04/2011 | US8029765 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors |
| 10/04/2011 | US8029764 Isolating an mRNA sample from feces; detecting renal dipeptidase mRNA in the sample; comparing the amount the mRNA in the sample to amounts of renal dipeptidase mRNA in normal subjects, wherein an elevated level indicates colorectal cancer |
| 10/04/2011 | CA2615917C Use of lipoxin compounds for inhibiting of tnf-(alpha)initiated neutrophil response |
| 10/04/2011 | CA2426959C Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 09/29/2011 | WO2011119654A1 Ligands for semiconductor nanocrystals |
| 09/29/2011 | WO2011119340A1 Smart contrast agent and method for detecting transition metal ions and treating related disorders |
| 09/29/2011 | WO2011117305A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
| 09/29/2011 | WO2011117236A1 Preparation of stabilised x-ray diagnostic composition |
| 09/29/2011 | WO2011116501A1 Establishment of rhesus monkey model of autoimmunity type 1 diabetes |
| 09/29/2011 | WO2011070212A3 Multifunctional nanostructures as trimodal mri/oi/spect diagnosis agents |
| 09/29/2011 | WO2011070203A3 Multifunctional vectorised nanostructures that can be used as trimodal (mri, oi and spect) diagnosis agents |
| 09/29/2011 | WO2011053901A3 Magnetic nanostructures as theranostic agents |
| 09/29/2011 | WO2011044377A3 Chelator-targeting ligand conjugates for cardiovascular imaging |
| 09/29/2011 | WO2011041701A3 Inplantable contrast agents and methods |
| 09/29/2011 | WO2010103116A3 Method of treating eczema |
| 09/29/2011 | US20110239310 Transgenic fish and uses thereof |
| 09/29/2011 | US20110237909 Systems, Circuits and Apparatus For In Vivo Detection of Biomolecule Concentrations Using Fluorescent Tags |
| 09/29/2011 | US20110236320 Ultrasound Contrast Agents And Process For The Preparation Thereof |
| 09/29/2011 | US20110236318 Animal model of an ejaculation-like reflex |
| 09/29/2011 | US20110236317 Tetrahydrotriazine compounds for treating diseases associated with ampk acitivity |
| 09/29/2011 | US20110236316 Peptide targeting imaging agents and methods of use thereof |
| 09/29/2011 | US20110236315 Ligands for Semiconductor Nanocrystals |
| 09/29/2011 | US20110236314 Method of detection and diagnosis of oral and nasopharyngeal cancers |
| 09/29/2011 | US20110236313 Human salty taste receptor and methods of modulating salty taste perception |
| 09/29/2011 | US20110236310 Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method |
| 09/29/2011 | US20110236309 Antagonists of ligands and uses thereof |
| 09/29/2011 | US20110236307 In vivo imaging method |
| 09/29/2011 | US20110236306 Compositions and methods for the removal of biofilms |
| 09/29/2011 | CA2793277A1 Preparation of stabilised x-ray diagnostic composition |
| 09/28/2011 | EP2368558A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
| 09/28/2011 | EP2367851A1 Antibody-targeted carrier for contrast agents |
| 09/28/2011 | EP2367805A2 Modified actinomycin-based nucleic acid stains and methods of their use |
| 09/28/2011 | EP2367576A2 Method for the production of scaffolds for tissue engineering, comprising the use of an anchoring unit, and scaffold produced therewith |
| 09/28/2011 | CN102203614A Imaging techniques |
| 09/28/2011 | CN102202722A Transdermal delivery in small animals or humans |
| 09/28/2011 | CN102202694A Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same |
| 09/28/2011 | CN102199656A Method and reagent for regulating and controlling development and transformation of bone marrow |
| 09/28/2011 | CN102199625A Construction method for miRNA (micro Ribonucleic Acid) transgenic mouse model |
| 09/28/2011 | CN102198278A Rhesus monkey retinal degeneration model, and drug screening method thereof |
| 09/28/2011 | CN101721719B Ultrasound contrast agent and preparation method thereof |
| 09/28/2011 | CN101337079B Process and apparatus for preparing a diagnostic or therapeutic agent |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/27/2011 | US8025866 Diagnosis of fasciolosis by skin test (intradermoreaction) using the antigen Fh8 (fasciolin) |
| 09/27/2011 | CA2540442C Contrast media for use in medical and diagnostic procedures and methods of using the same |
| 09/27/2011 | CA2503982C Sincalide formulations |
| 09/22/2011 | WO2011116341A2 Longevity of hyperpolarized enhanced signals for nmr spectroscopy |
| 09/22/2011 | WO2011115555A1 System for improved delivery of gene modulating compounds |
| 09/22/2011 | WO2011115342A1 Oral contrast medium for contrast of small intestine |
| 09/22/2011 | WO2011113616A1 A nanoparticle comprising a micelle formed by an amphiphilic block- copolymer and encapsulating a gadolinium complex |
| 09/22/2011 | WO2011113140A1 Magnetic apparatus used for drug delivery |
| 09/22/2011 | WO2011113107A1 Kit and method for detecting porous dental hydroxy apatite |
| 09/22/2011 | WO2011053618A3 Hydroxyl-terminated dendrimers |
| 09/22/2011 | US20110229416 Amphiphilic macromolecules for solubilizing nanocrystals |
| 09/22/2011 | US20110229415 Semi-synthetic antibodies as recognition elements |
| 09/22/2011 | US20110229414 Contrast Agents For Detecting Protease Activity By Means Of Hyperpolarization And For Stratifying Patients |
| 09/22/2011 | US20110229413 Treatment of amyloidogenic diseases |
| 09/22/2011 | US20110229412 Animal model of central neuropathic pain and mehtods of making and using the same |
| 09/22/2011 | US20110229411 Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment |
| 09/22/2011 | US20110229410 Technetium-dipyridine complexes, and methods of use thereof |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110229407 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
| 09/22/2011 | CA2793698A1 Kit and method for detecting porous dental hydroxy apatite |
| 09/22/2011 | CA2793209A1 Nonsurgical determination of organ transplant condition |
| 09/21/2011 | EP2366793A1 Orthoptic reconstituted human breast tumor model in mouse |
| 09/21/2011 | EP2366693A1 Nitroimidazole-amino acid compound type nuclide hypoxia imaging agent and intermediates for preparing them |
| 09/21/2011 | EP2366387A1 Ceramic matrix for incorporating controlled release drugs, a tablet, method for obtaining the ceramic matrix and method for producing a tablet |
| 09/21/2011 | EP2365777A1 Method for determining the liver function of a human being by quantitatively measuring the metabolism of substrates |
| 09/21/2011 | EP2043695B1 Models for vaccine assessment |
| 09/21/2011 | EP1581047B1 Radiopaque animal chew |
| 09/21/2011 | EP1531873B1 Agent delivery particle |
| 09/21/2011 | CN102196823A Imaging agents of fibrotic diseases |
| 09/21/2011 | CN102196773A Molecular imaging |
| 09/21/2011 | CN102190729A Anti-human CD80 bivalent dimer and application thereof |
| 09/21/2011 | CN102188723A Cleaning-free medical ultrasonic couplant, and preparation method thereof |
| 09/21/2011 | CN102188722A Ferrous iron-containing magnetic resonance imaging contrast agent |
| 09/21/2011 | CN102188721A Liquid preparation of gastrointestinal series agent for gastrointestinal series, and preparation method thereof |
| 09/21/2011 | CN102188720A Method for studying base of medicinal effect materials |
| 09/21/2011 | CN102188442A Construction method of animal model of chronic inflammation |
| 09/21/2011 | CN102188380A Double-target tumor nanoliposome and preparation method thereof |
| 09/20/2011 | US8021894 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 09/20/2011 | US8021671 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 09/20/2011 | US8021645 Clostridium difficile associated diseases; gastrointestinal tract degradation resistance |
| 09/20/2011 | US8021644 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/15/2011 | WO2011112970A2 Compositions and methods for bioconjugation to quantum dots |
| 09/15/2011 | WO2011111698A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 09/15/2011 | WO2011111694A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 09/15/2011 | WO2011110589A1 Radiopaque, non- biodegradable, water - insoluble iodinated benzyl ethers of poly (vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof |
| 09/15/2011 | WO2011110347A2 Compositions for colon lavage and methods of making and using same |
| 09/15/2011 | WO2011050052A3 Protein agent for diabetes treatment and beta cell imaging |
| 09/15/2011 | WO2011044545A3 Methods and compositions for targeted imaging |